Treatment regimen | Females (N = 54) n (%) | Males (N = 34) n (%) | p-value* |
---|---|---|---|
No ongoing therapies | 1 (1.9) | 0 (0.0) | 0.281 |
ICS | 43 (79.6) | 31 (91.2) | |
ICS only | 3 (5.6) | 3 (8.8) | |
ICS/LABA only | 33 (61.1) | 21 (61.8) | |
ICS + ICS/LABA | 7 (13.0) | 7 (20.6) | |
OCS | 10 (18.5) | 3 (8.8) | |
ICS/LABA + OCS | 5 (9.3) | 1 (2.9) | |
ICS + ICS/LABA + OCS | 3 (5.6) | 0 (0.0) | |
ICS + OCS | 2 (3.7) | 2 (5.9) |